Recent findings from a randomized controlled trial further underscore the advantages of NT-proBNP, revealing that implantable loop-recorder screening correlates with a greater reduction in stroke risk among patients exhibiting higher NT-proBNP levels [31]. This evidence concerns the gene NPPB and stroke disorder.